Valproic acid topical - Amorepacific

Drug Profile

Valproic acid topical - Amorepacific

Alternative Names: VPA spray - Amorepacific Corporation

Latest Information Update: 10 Jan 2017

Price : $50

At a glance

  • Originator Amorepacific
  • Class Antiepileptic drugs; Antimigraines; Nootropics; Small molecules
  • Mechanism of Action Glycogen synthase kinase 3 beta inhibitors; Wnt signalling pathway stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Male pattern baldness

Most Recent Events

  • 30 Apr 2016 No recent reports on development identified - Phase-II for Male pattern baldness in South Korea (Topical)
  • 15 Mar 2016 Biomarkers information updated
  • 04 Jun 2012 Seoul National University Hospital & Amorepacific complete enrolment in its phase II trial for Male pattern baldness in South Korea (NCT01548066)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top